Influences of ionic dissolution products of dicalcium silicate coating on osteoblastic proliferation, differentiation and gene expression

Acta Biomaterialia

Volumn 5, Issue 4, 2009, Pages 1284-1293

  Sun, Junying ^a   Wei, Li ^a   Liu, Xuanyong ^b   Li, Jianyou ^a   Li, Baoe ^b   Wang, Guocheng ^b   Meng, Fanhao ^b  

^a SOOCHOW UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF CERAMICS   (China)

Author keywords

Dicalcium silicate; Differentiation; MG63; Osteoblasts; Proliferation

Indexed keywords

CYTOLOGY; DISSOLUTION; OSTEOBLASTS; PHOSPHATASES; PLASMA JETS; PLASMA SPRAYING; SILICATES;

DICALCIUM SILICATE; DIFFERENTIATION; EXPERIMENTAL GROUPS; GENES EXPRESSION; IONIC-DISSOLUTION PRODUCTS; MG-63 OSTEOBLASTS; MG63; OSTEOBLAST-LIKE CELLS; PROLIFERATION; SILICATE COATINGS;

GENE EXPRESSION;

ALIZARIN RED S; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CALCIUM SILICATE; COLLAGEN TYPE 1; DICALCIUM SILICATE; OSTEOCALCIN; SMAD1 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BONE MINERALIZATION; CELL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DISSOLUTION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MATERIAL COATING; NUCLEOTIDE SEQUENCE; OSTEOBLAST; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 64249096970     PISSN: 17427061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.actbio.2008.10.011     Document Type: Article

References (39)

1. Webster T.J. In: Ying J.Y. (Ed). Advances in chemical engineering (2001), Academic Press, New York 125
2. Vercaigne S., Wolke J.C., Naert I., and Jansen J.A. The effect of titanium plasma sprayed implants on trabecular bone healing in the goat. Biomaterials 19 (1998) 1093-1099
3. Lynn A.K., and DuQuesnay D.L. Hydroxyapatite-coated Ti-6Al-4V part 2: the effects of post-deposition heat treatment at low temperatures. Biomaterials 23 (2002) 1947-1953
4. Bloebaum R.D., Beeks D., Dorr L.D., Savory C.G., Dupont J.A., and Hofmann A.A. Complications with hydroxyapatite particulate separation in total hip arthroplasty. Clin Orthop 298 (1994) 19-26
5. Dalton J.E., and Cook S.D. In vivo mechanical and histological characteristics of HA-coated implants vary with coating vendor. J Biomed Mater Res 29 (1995) 239-245
6. Sun J.S., Lin F.H., Hung T.Y., Tsuang Y.H., Chang W.H., and Liu H.C. The influence of hydroxyapatite particles on osteoclast cell activities. J Biomed Mater Res 45 (1999) 311-321
7. Yang Y.C., Hang E., and Lee S.Y. Mechanical properties and Young's modulus of plasma-sprayed hydroxyapatite coating on Ti substrate in simulated body fluid. J Biomed Mater Res 67A (2003) 886-889
8. Suchanek W., and Yoshimura M. Processing and properties of hydroxyapatite-based biomaterials for use as hard tissue replacement implants. J Mater Res 13 (1998) 94-117
9. Salinas A.J., Vallet-Regí M., and Izquierdo-Barba I. Biomimetic apatite deposition on calcium silicate gel glasses. J Sol-gel Sci Technol 21 (2001) 13-25
10. Xie Y.T., Liu X.Y., Chu P.K., Zheng X.B., and Ding C.X. Bioactive titanium-particle-containing dicalcium silicate coating. Surf Coat Technol 200 (2005) 1950-1953
11. Oonishi H., et al. Quantitative comparison of bone growth behavior in granules of bioglass, A-W glass-ceramic, and hydroxyapatite. J Biomed Mater Res 51 (2000) 37-46
12. Kokubo T. Surface chemistry of bioactive glass-ceramics. J Non-Cryst Solids 120 (1990) 138-151
13. Liu X.Y., Xie Y.T., Ding C.X., and Chu P.K. Early apatite deposition and osteoblasts growth on plasma sprayed dicalcium silicate coating. J Biomed Mater Res 74A (2005) 356-365
14. Gough G.E., Jones J.R., and Hench L.L. Nodule formation and mineralization of human primary osteoblasts cultured on a porous bioactive glass scaffold. Biomaterials 25 (2004) 2039-2046
15. Chang Y.L., Stanford C.M., and Keller J.C. Calcium and phosphate supplementation promotes bone cell mineralization: implications for hydroxyapatite (HA)-enhanced bone formation. J Biomed Mater Res 52 (2000) 270-278
16. Ralstion S.H., Todd D., Helfrich M., Benjamin N., and Grabowski P.S. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 135 (1994) 330-336
17. Spinella-jaegle S., et al. Opposite effects of bone morphogenetic protein-2 and transforming growth factor-β1 on osteoblast differentiation. Bone 29 (2001) 323-330
18. Borsari V., et al. Comparative in vitro study on a ultra-high roughness and dense titanium coating. Biomaterials 26 (2005) 4948-4955
19. Christodoulou I., Buttery L.D.K., Tai G.P., Hench L.L., and Polak J.M. Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products. J Biomed Mater Res B: Appl Biomater 77B (2006) 431-446
20. ® 45S5 dissolution. J Biomed Mater Res 55 (2001) 151-157
21. Reffitt D.M., et al. Orthosilicic acid stimulates collagen 1 synthesis and osteoblastic differentiation in human osteoblast-like cells in vitro. Bone 32 (2003) 127-135
22. Hench L.L. Bioactive ceramics. Ann NY Acad Sci 523 (1988) 54-71
23. Sepulveda P., Jones J.R., and Hench L.L. In vitro dissolution of melt-derived 45S5 and sol-gel derived 58S bioactive glasses. J Biomed Mater Res 61 (2001) 301-311
24. Choi J.Y., et al. Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci USA 98 (2001) 8650-8655
25. Pratap J., et al. Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. Cancer Res 63 (2003) 5357-5362
26. Boanini E., Torricelli P., Gazzano M., Giardino R., and Bigi A. Nanocomposites of hydroxyapatite with aspartic acid and glutamic acid and their interaction with osteoblast-like cells. Biomaterials 27 (2006) 4428-4433
27. Tsuji K., et al. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat Genet 38 (2006) 1424-1429
28. Piek E., Heldin C.H., and Ten Dijke P. Specificity, diversity, and regulation in TGF-β superfamily signaling. FASEB J 13 (1999) 2105-2124
29. Wrana J.L. Regulation of Smad activity. Cell 100 (2000) 189-192
30. Miyazono K. TGF-β signaling by Smad proteins. Cytok Growth Factor Rev 11 (2000) 15-22
31. Keeting P.E., Oursler M.J., Wiegand K.E., Bonde S.K., Spelsberg T.C., and Riggs B.L. Zeolite A increases proliferation, differentiation, and transforming factor β production in normal adult osteoblast-like cells in vitro. J Bone Miner Res 7 (1992) 1281-1289
32. Gao T.J., Aro H.T., Ylanen H., and Vuorio E. Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro. Biomaterials 22 (2001) 1475-1483
33. Bergeron E., Marquis M.E., Chrétien I., and Faucheux N. Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres. J Mater Sci: Mater Med 18 (2007) 255-263
34. Clarke S.A., Hoskins N.L., Jordan G.R., and Marsh D.R. Healing of an ulnar defect using a proprietary TCP bone graft substitute, JAX™, in association with autologous osteogenic cells and growth factors. Bone 40 (2007) 939-947
35. Kruyt M.C., Dhert W.J., Oner F.C., van Blitterswijk C.A., Verbout A.J., and de Bruijn J.D. Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 28 (2007) 1798-1805
36. Sachse A., et al. Osteointegration of hydroxyapatite-titanium implants coated with nonglycosylated recombinant human bone morphogenetic protein-2 (BMP-2) in aged sheep. Bone 37 (2005) 699-710
37. Kimura N., Matsuo R., Shibuya H., Nakashima K., and Taga T. BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem 275 (2000) 17647-17652
38. Hay E., Lemonnier J., Fromigue O., and Marie P.J. Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway. J Biol Chem 276 (2001) 29028-29036
39. Poynton A.R., and Lane J.M. Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 27 (2002) S40-S48